The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title Announcement Number
Activity Code
Clinical Trials Status Expiration Date
Sort descending
Program Official
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-23-279 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
01/08/2027
Edward Sauter, M.D., Ph.D.
Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics PAR-23-280 (R21 Clinical Trial Not Allowed)
R21
Clinical Trial Not Allowed
01/08/2027
Edward Sauter, M.D., Ph.D.
Cancer Prevention and Control Clinical Trials Grant Program PAR-24-072 (R01 Clinical Trial Required)
R01
Clinical Trial Required
01/08/2027
Brandy Heckman-Stoddard, Ph.D., M.P.H.
National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis PAR-24-085 (R01 Clinical Trial Required)
R01
Clinical Trial Required
01/08/2027
Brandy Heckman-Stoddard, Ph.D., M.P.H.
HEAL Initiative: Studies to Enable Analgesic Discovery RFA-NS-25-012 (R61/R33 - Clinical Trial Not Allowed)
R61, R33
Clinical Trial Not Allowed
01/16/2027
Rachel Altshuler, Ph.D.
The NCI Worta McCaskill-Stevens Career Development Award for Community Oncology and Prevention Research PAR-24-153 (K12 Clinical Trial Optional)
K12
Clinical Trial Optional
02/19/2027
Brandy Heckman-Stoddard, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Basic Mechanisms of Cannabis and Cannabinoid Action in Cancer NOT-CA-22-085
05/08/2027
Sharon Ross, Ph.D., M.P.H.
